Contribution of CgPDR1-Regulated Genes in Enhanced Virulence of Azole-Resistant Candida glabrata

In Candida glabrata, the transcription factor CgPdr1 is involved in resistance to azole antifungals via upregulation of ATP binding cassette (ABC)-transporter genes including at least CgCDR1, CgCDR2 and CgSNQ2. A high diversity of GOF (gain-of-function) mutations in CgPDR1 exists for the upregulation of ABC-transporters. These mutations enhance C. glabrata virulence in animal models, thus indicating that CgPDR1 might regulate the expression of yet unidentified virulence factors. We hypothesized that CgPdr1-dependent virulence factor(s) should be commonly regulated by all GOF mutations in CgPDR1. As deduced from transcript profiling with microarrays, a high number of genes (up to 385) were differentially regulated by a selected number (7) of GOF mutations expressed in the same genetic background. Surprisingly, the transcriptional profiles resulting from expression of GOF mutations showed minimal overlap in co-regulated genes. Only two genes, CgCDR1 and PUP1 (for PDR1 upregulated and encoding a mitochondrial protein), were commonly upregulated by all tested GOFs. While both genes mediated azole resistance, although to different extents, their deletions in an azole-resistant isolate led to a reduction of virulence and decreased tissue burden as compared to clinical parents. As expected from their role in C. glabrata virulence, the two genes were expressed as well in vitro and in vivo. The individual overexpression of these two genes in a CgPDR1-independent manner could partially restore phenotypes obtained in clinical isolates. These data therefore demonstrate that at least these two CgPDR1-dependent and -upregulated genes contribute to the enhanced virulence of C. glabrata that acquired azole resistance.

[1]  B. Posteraro,et al.  Loss of Mitochondrial Functions Associated with Azole Resistance in Candida glabrata Results in Enhanced Virulence in Mice , 2011, Antimicrobial Agents and Chemotherapy.

[2]  A. Näär,et al.  Differential Roles of Transcriptional Mediator Subunits in Regulation of Multidrug Resistance Gene Expression in Saccharomyces cerevisiae , 2010, Molecular biology of the cell.

[3]  T. Myers,et al.  Microarray and Molecular Analyses of the Azole Resistance Mechanism in Candida glabrata Oropharyngeal Isolates , 2010, Antimicrobial Agents and Chemotherapy.

[4]  M. Mallié,et al.  Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program. , 2010, Diagnostic microbiology and infectious disease.

[5]  E. Sionov,et al.  Cryptococcus neoformans Overcomes Stress of Azole Drugs by Formation of Disomy in Specific Multiple Chromosomes , 2010, PLoS pathogens.

[6]  J. Šubík,et al.  Molecular analysis of Candida glabrata clinical isolates , 2010, Mycopathologia.

[7]  K. Kuchler,et al.  Candida glabrata Persistence in Mice Does Not Depend on Host Immunosuppression and Is Unaffected by Fungal Amino Acid Auxotrophy , 2009, Infection and Immunity.

[8]  S. Fillinger,et al.  Fungicide-Driven Evolution and Molecular Basis of Multidrug Resistance in Field Populations of the Grey Mould Fungus Botrytis cinerea , 2009, PLoS pathogens.

[9]  E. Sionov,et al.  Heteroresistance to Fluconazole in Cryptococcus neoformans Is Intrinsic and Associated with Virulence , 2009, Antimicrobial Agents and Chemotherapy.

[10]  C. Lass‐Flörl.  The changing face of epidemiology of invasive fungal disease in Europe , 2009, Mycoses.

[11]  G. Fadda,et al.  The ABC transporter-encoding gene AFR1 affects the resistance of Cryptococcus neoformans to microglia-mediated antifungal activity by delaying phagosomal maturation. , 2009, FEMS yeast research.

[12]  G. Fadda,et al.  Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence , 2009, PLoS pathogens.

[13]  Jacques van Helden,et al.  RSAT: regulatory sequence analysis tools , 2008, Nucleic Acids Res..

[14]  Christine Noffz,et al.  A New Purple Fluorescent Color Marker for Genetic Studies in Saccharomyces cerevisiae and Candida albicans , 2008, Genetics.

[15]  G. Fadda,et al.  The ATP‐binding cassette transporter–encoding gene CgSNQ2 is contributing to the CgPDR1‐dependent azole resistance of Candida glabrata , 2008, Molecular microbiology.

[16]  D. Denning,et al.  EUCAST technical note on fluconazole. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  R. Homayouni,et al.  The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicans , 2007, PLoS pathogens.

[18]  R. Homayouni,et al.  Genome-Wide Expression and Location Analyses of the Candida albicans Tac1p Regulon , 2007, Eukaryotic Cell.

[19]  Kailash Gulshan,et al.  Multidrug Resistance in Fungi , 2007, Eukaryotic Cell.

[20]  B. Cormack,et al.  A family of glycosylphosphatidylinositol-linked aspartyl proteases is required for virulence of Candida glabrata , 2007, Proceedings of the National Academy of Sciences.

[21]  M. Pfaller,et al.  Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.

[22]  D. Andersson.  The biological cost of mutational antibiotic resistance: any practical conclusions? , 2006, Current opinion in microbiology.

[23]  R. Homayouni,et al.  Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome‐wide expression studies , 2006, Molecular microbiology.

[24]  J. Bennett,et al.  Candida glabrata PDR1, a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite Mutants , 2006, Antimicrobial Agents and Chemotherapy.

[25]  M. Ruhnke,et al.  Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts. , 2006, Current drug targets.

[26]  G. Fadda,et al.  Role of AFR1, an ABC Transporter-Encoding Gene, in the In Vivo Response to Fluconazole and Virulence of Cryptococcus neoformans , 2006, Infection and Immunity.

[27]  M. Zupancic,et al.  A yeast by any other name: Candida glabrata and its interaction with the host. , 2005, Current opinion in microbiology.

[28]  James B. Anderson.  Evolution of antifungal-drug resistance: mechanisms and pathogen fitness , 2005, Nature Reviews Microbiology.

[29]  M. Zupancic,et al.  Nicotinic Acid Limitation Regulates Silencing of Candida Adhesins During UTI , 2005, Science.

[30]  G. Fadda,et al.  Mechanisms of Azole Resistance in Clinical Isolates of Candida glabrata Collected during a Hospital Survey of Antifungal Resistance , 2005, Antimicrobial Agents and Chemotherapy.

[31]  B. Arthington-Skaggs,et al.  Rapid Acquisition of Stable Azole Resistance by Candida glabrata Isolates Obtained before the Clinical Introduction of Fluconazole , 2005, Antimicrobial Agents and Chemotherapy.

[32]  M. Dryden,et al.  Preventing parasites in cats. , 2005, Veterinary therapeutics : research in applied veterinary medicine.

[33]  D. Sanglard,et al.  TAC1, Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2 , 2004, Eukaryotic Cell.

[34]  R. Kolter,et al.  The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. , 2004, Gene.

[35]  B. Akache,et al.  Complex Interplay Among Regulators of Drug Resistance Genes in Saccharomyces cerevisiae* , 2004, Journal of Biological Chemistry.

[36]  K. Marr,et al.  Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis , 2004, Antimicrobial Agents and Chemotherapy.

[37]  J. Cooper,et al.  The role of the lissencephaly protein Pac1 during nuclear migration in budding yeast , 2003, The Journal of cell biology.

[38]  J. Bennett,et al.  Function of Candida glabrata ABC transporter gene, PDH1 , 2003, Yeast.

[39]  Rudy Pandjaitan,et al.  The yeast zinc finger regulators Pdr1p and Pdr3p control pleiotropic drug resistance (PDR) as homo‐ and heterodimers in vivo , 2002, Molecular microbiology.

[40]  B. Akache,et al.  New Regulators of Drug Sensitivity in the Family of Yeast Zinc Cluster Proteins* , 2002, The Journal of Biological Chemistry.

[41]  B. Akache,et al.  Zinc Cluster Protein Rdr1p Is a Transcriptional Repressor of thePDR5 Gene Encoding a Multidrug Transporter* , 2002, The Journal of Biological Chemistry.

[42]  D. Sanglard,et al.  Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. , 2002, The Lancet. Infectious diseases.

[43]  C. Jacq,et al.  An artificial transcription activator mimics the genome‐wide properties of the yeast Pdr1 transcription factor , 2001, EMBO reports.

[44]  D. Sanglard,et al.  Role of ATP-Binding-Cassette Transporter Genes in High-Frequency Acquisition of Resistance to Azole Antifungals in Candida glabrata , 2001, Antimicrobial Agents and Chemotherapy.

[45]  Xiaoting Zhang,et al.  Cross-talk between Transcriptional Regulators of Multidrug Resistance in Saccharomyces cerevisiae * , 2001, The Journal of Biological Chemistry.

[46]  D. Sanglard,et al.  The ATP Binding Cassette Transporter GeneCgCDR1 from Candida glabrata Is Involved in the Resistance of Clinical Isolates to Azole Antifungal Agents , 1999, Antimicrobial Agents and Chemotherapy.

[47]  C. Brandl,et al.  Identification of Native Complexes Containing the Yeast Coactivator/Repressor Proteins NGG1/ADA3 and ADA2* , 1997, The Journal of Biological Chemistry.

[48]  C. Brandl,et al.  Transcriptional Activation by Yeast PDR1p Is Inhibited by Its Association with NGG1p/ADA3p* , 1996, The Journal of Biological Chemistry.